News

The drug will be studied in combination with radiologic therapy, and other drugs and biologics in the treatment of solid tumors including esophageal, gastric and pancreatic cancers. The

The research, presented this week at the annual meeting of the American College of Gastroenterology, found that a significantly higher proportion of patients who responded to an induction

A total of 50 patients are to be entered into the trial, which will be conducted in Singapore, Malaysia and Vietnam. The study, which was designed in collaboration

The application seeks approval for use of Erbitux in combination with radiation for locally or regionally advanced head and neck cancer, and as monotherapy in patients with recurrent

The chemically synthesized adjuvant will be tested by Sanofi Pasteur to determine its ability to enhance the immune response to a broad range of vaccines. Under the terms

The company believes that completion of this trial will allow the launch of a pivotal phase III trial for the drug. This phase IIb clinical study is designed

In a paper published in Nature the scientists describe the rational design of a potential new class of chemically modified RNA-based drugs, called ‘antagomirs’, that specifically silence miRNAs

The new project will expand clinical evaluation of the world’s most advanced malaria vaccine candidate, known as RTS,S. If all the project milestones are achieved, this agreement will

The approval is specifically for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to, or has